Patient Compliance Packaging Q&A
-
Asked September 17th, 2009
Answer:
It might be best to answer the last question first: “What does your organization follow?” We follow cGMP guidelines. We run all pharmaceutical orders as individual structures and copies.
Here are the rest of the answers, broken out:
Question: At what level is implementation of W.I.P. segregation expected in the pharma industry?
Answer: Keep all orders segregated by individual structures and copy. The best way to handle this is to enter every order individually. W.I.P. management throughout the operation can be handled several ways; the most common practice is wrapping and labeling pallets and placing them in separated rows on the manufacturing floor.
Question: My concern is not to over-engineer this process while meeting the needs of our customers. So questions are as follows. Is it a common practice to cage W.I.P. material?
Answer: By running every structure and every copy individually, you’re set up for success, not for over-engineering the process. Segregation in cages is not necessary for basic copy separation protocol.
Question: Do people in this industry use individual cages for separate orders produced?
Answer: That is one option. Another option is simply wrapping each pallet through Work in Process.
Question: Or is it more of a common practice to segregate job orders on clearly marked pallets, and control them within one secured cage area?
Answer: Storing pallets in a secured caged area is not necessary. As long as the pallets have been wrapped and clearly marked, you don’t have to have them in a caged area.



